Watson R D, Smith A G, Levy J G
Br J Cancer. 1975 Sep;32(3):300-9. doi: 10.1038/bjc.1975.228.
Antisera to extracts of a variety of bronchogenic carcinoma were raised in rabbits and extensively absorbed with immunoadsorbents prepared with normal lung extracts cyanogen bromide linked to Sepharose 4B, and glutaraldehyde insolubilized normal lung extracts. The antisera were tested by immunodiffusion against a panel of extracts from a variety of bronchogenic carcinoma, foetal lung extracts and pools of normal lung extracts. The results indicate that two distinct antigenic components are associated with bronchogenic carcinoma; one which is present in a high percentage of the tumour extracts tested and appears to have partial identity with a foetal lung component, and one (or more) which is not foetal and appears to have higher cross-reactivity (but not exclusively) with tumours of the same pathological type. Attempts to detect either antibody or antigens relating to these components in the serum of patients with bronchogenic carcinoma by these techniques were unsuccessful. The foetal cross-reacting component was neither carcinoembryonic antigen and alpha1-foetoprotein.
用多种支气管源性癌提取物对家兔进行免疫,制备抗血清,并分别用与溴化氰偶联的琼脂糖4B正常肺提取物免疫吸附剂以及戊二醛固定的正常肺提取物对其进行广泛吸收处理。采用免疫扩散法,用一系列支气管源性癌提取物、胎儿肺提取物以及正常肺提取物混合物对这些抗血清进行检测。结果表明,支气管源性癌与两种不同的抗原成分相关;一种存在于所检测的大部分肿瘤提取物中,似乎与胎儿肺成分有部分相同之处;另一种(或多种)并非胎儿来源,似乎与相同病理类型的肿瘤具有更高的交叉反应性(但并非唯一)。采用这些技术检测支气管源性癌患者血清中与这些成分相关的抗体或抗原均未成功。胎儿交叉反应成分既不是癌胚抗原也不是甲胎蛋白。